These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 19365143

  • 21. The effect of intrauterine growth restriction on circulating surfactant protein D concentrations in the perinatal period.
    Briana DD, Gourgiotis D, Baka S, Boutsikou M, Vraila VM, Boutsikou T, Hassiakos D, Malamitsi-Puchner A.
    Reprod Sci; 2010 Jul; 17(7):653-8. PubMed ID: 20360592
    [Abstract] [Full Text] [Related]

  • 22. Perinatal collagen turnover markers in intrauterine growth restriction.
    Gourgiotis D, Briana DD, Georgiadis A, Boutsikou M, Baka S, Marmarinos A, Hassiakos D, Malamitsi-Puchner A.
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
    [Abstract] [Full Text] [Related]

  • 23. Variations in circulating osteoprotegerin and soluble RANKL during diurnal and menstrual cycles in young women.
    Shimizu M, Onoe Y, Mikumo M, Miyabara Y, Kuroda T, Yoshikata R, Ishitani K, Okano H, Ohta H.
    Horm Res; 2009 Sep; 71(5):285-9. PubMed ID: 19339793
    [Abstract] [Full Text] [Related]

  • 24. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM.
    Menopause; 2007 Sep; 14(5):913-8. PubMed ID: 17667143
    [Abstract] [Full Text] [Related]

  • 25. RANKL/RANK/OPG system and bone status in females with anorexia nervosa.
    Ostrowska Z, Ziora K, Oświęcimska J, Swiętochowska E, Szapska B, Wołkowska-Pokrywa K, Dyduch A.
    Bone; 2012 Jan; 50(1):156-60. PubMed ID: 22001124
    [Abstract] [Full Text] [Related]

  • 26. OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration.
    Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Lubrano C, Bonaiuto M, D'Anna R, Cannata ML, Corrado F, Cancellieri F, Faraci M, Marini R, Adamo EB, Wilson S, Squadrito F.
    J Bone Miner Res; 2008 May; 23(5):715-20. PubMed ID: 18433304
    [Abstract] [Full Text] [Related]

  • 27. The role of the anti-angiogenic factor endostatin in intrauterine growth restriction.
    Malamitsi-Puchner A, Boutsikou T, Economou E, Makrakis E, Iliodromiti Z, Kouskouni E, Hassiakos D.
    J Soc Gynecol Investig; 2005 Apr; 12(3):195-7. PubMed ID: 15784505
    [Abstract] [Full Text] [Related]

  • 28. Cord blood survivin concentrations in human full-term normal and complicated pregnancies.
    Malamitsi-Puchner A, Baka S, Boutsikou M, Liosi S, Gourgiotis D, Protonotariou E, Hassiakos D, Briana DD.
    In Vivo; 2009 Apr; 23(1):139-42. PubMed ID: 19368138
    [Abstract] [Full Text] [Related]

  • 29. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
    Ricci P, Tauchmanova L, Risitano AM, Carella C, Mazziotti G, Lombardi G, Colao A, Rotoli B, Selleri C.
    Transplantation; 2006 Dec 15; 82(11):1449-56. PubMed ID: 17164716
    [Abstract] [Full Text] [Related]

  • 30. Perinatal circulating visfatin levels in intrauterine growth restriction.
    Malamitsi-Puchner A, Briana DD, Boutsikou M, Kouskouni E, Hassiakos D, Gourgiotis D.
    Pediatrics; 2007 Jun 15; 119(6):e1314-8. PubMed ID: 17502346
    [Abstract] [Full Text] [Related]

  • 31. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer.
    Mikosch P, Igerc I, Kudlacek S, Woloszczuk W, Gallowitsch HJ, Kresnik E, Stettner H, Grimm G, Lind P, Pietschmann P.
    Eur J Clin Invest; 2006 Aug 15; 36(8):566-73. PubMed ID: 16893379
    [Abstract] [Full Text] [Related]

  • 32. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth.
    Briana DD, Boutsikou M, Baka S, Gourgiotis D, Marmarinos A, Hassiakos D, Malamitsi-Puchner A.
    Neonatology; 2008 Aug 15; 93(3):153-7. PubMed ID: 17878741
    [Abstract] [Full Text] [Related]

  • 33. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I, Larijani B, Vahdat K, Assadi M, Jafari SM, Ahmadi E, Movahed A, Moradhaseli F, Sanjdideh Z, Obeidi N, Amiri Z.
    Menopause; 2009 Aug 15; 16(5):950-5. PubMed ID: 19387415
    [Abstract] [Full Text] [Related]

  • 34. Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein.
    Sennels HP, Jacobsen S, Jensen T, Hansen MS, Ostergaard M, Nielsen HJ, Sørensen S.
    Scand J Clin Lab Invest; 2007 Aug 15; 67(8):821-35. PubMed ID: 17852826
    [Abstract] [Full Text] [Related]

  • 35. Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1.
    Briana DD, Gourgiotis D, Georgiadis A, Boutsikou M, Baka S, Marmarinos A, Hassiakos D, Malamitsi-Puchner A.
    Metabolism; 2012 Mar 15; 61(3):335-40. PubMed ID: 21944272
    [Abstract] [Full Text] [Related]

  • 36. Circulating apelin concentrations in mother/infant pairs at term.
    Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Briana DD.
    Acta Paediatr; 2007 Dec 15; 96(12):1751-4. PubMed ID: 18001333
    [Abstract] [Full Text] [Related]

  • 37. [Concentration measurement of the OPG and sRANKL of peripheral blood among normal healthy people].
    Zhu LL, Bao NR, Zhou LW, Guo T, Zeng XF, Zhao JN.
    Zhongguo Gu Shang; 2010 Feb 15; 23(2):87-9. PubMed ID: 20345025
    [Abstract] [Full Text] [Related]

  • 38. Fetal concentrations of the growth factors TGF-α and TGF-β1 in relation to normal and restricted fetal growth at term.
    Briana DD, Liosi S, Gourgiotis D, Boutsikou M, Marmarinos A, Baka S, Hassiakos D, Malamitsi-Puchner A.
    Cytokine; 2012 Oct 15; 60(1):157-61. PubMed ID: 22732125
    [Abstract] [Full Text] [Related]

  • 39. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J.
    J Matern Fetal Neonatal Med; 2007 Jul 15; 20(7):527-32. PubMed ID: 17674266
    [Abstract] [Full Text] [Related]

  • 40. Markers of insulin sensitivity in placentas and cord serum of intrauterine growth-restricted newborns.
    Street ME, Volta C, Ziveri MA, Viani I, Bernasconi S.
    Clin Endocrinol (Oxf); 2009 Sep 15; 71(3):394-9. PubMed ID: 19226262
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.